Advertisements

Ксилен

Quick links to important sections

Ксилен

Advertisements
Advertisements

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Ксилен

Property Description
Active Ingredient Xylometazoline
Form Nasal drops, Nasal spray
Pharmacological Class Local Vasoconstrictor, alpha-Adrenomimetic
Common Use Symptomatic relief of nasal congestion
Origin Synthetic compound

Ксилен is a pharmaceutical preparation intended for local use in rhinology, defined by its active component, Xylometazoline (often used as the hydrochloride salt). This medicine is chemically a synthetic compound, specifically an imidazoline derivative, categorized as a powerful Local Vasoconstrictor. Xylometazoline belongs to the class of sympathomimetic amines and is used to relieve nasal and nasopharyngeal mucosal congestion. The primary function of this drug is to address the swelling within the nasal passages.


What Type of Medicine is Ксилен?

Ксилен belongs to the pharmacological class of sympathomimetic amines and is scientifically categorized as an alpha-adrenergic agonist. Xylometazoline is characterized by a rapid onset and efficacy in reducing mucosal swelling. This type of medicine is a nasal decongestant, which functions by reducing swelling in the nasal lining. This establishes the medicine’s role as focused on offering symptomatic relief for airway obstruction, such as during a typical upper respiratory infection.

Composition and Form: Nasal Solution

Ксилен is available as a solution for intranasal local application, typically supplied as either nasal drops or a metered-dose nasal spray. It is a single-component preparation, which is a key characteristic, with Xylometazoline dissolved in a basic aqueous solution. This method of delivery ensures the active substance reaches the nasal mucosa efficiently, providing a targeted effect to reduce local swelling. Ксилен is formulated in specific concentrations to accommodate both adult and pediatric patient groups.

General Purpose of a Vasoconstrictor

The general purpose of this medicine is to rapidly and effectively alleviate the core symptom of a blocked or stuffy nose caused by nasal congestion. This effect is achieved through its primary mechanism: the swift narrowing of small blood vessels in the nasal tissues, which is known as vasoconstriction. This action quickly reduces the excess fluid and swelling, known as mucosal edema, thereby physically opening the congested nasal passages and facilitating air passage.

Regulatory References

  1. Xylometazoline Summary of Product Characteristics (SmPC)
Advertisements

What side effects are possible with Ксилен?

Possible Side Effects and Safety Information

The safety profile of Ксилен (Xylene) is defined by its classifications as an irritant and a central nervous system (CNS) depressant, with risks directly tied to the level and duration of exposure, primarily through inhalation and skin contact.


Adverse Reactions and Toxicity Profile

Adverse reactions typically involve the Nervous System, Respiratory System, and Skin. Key adverse reactions, which intensify with higher concentrations, include:

  • CNS Effects: Headache, dizziness, nausea, vomiting, confusion, impaired concentration, slurred speech, loss of balance, and, in cases of severe acute overexposure, loss of consciousness or coma.
  • Irritation: Redness and pain in the eyes, nose, throat, and respiratory tract. Repeated skin contact can cause dermatitis, dryness, cracking, and potential absorption.
  • Systemic Damage: Prolonged or repeated high-level exposure is associated with potential damage to the liver and kidneys. Cardiovascular effects, such as increased heart palpitation and ventricular arrhythmias, have also been reported.

Serious Safety Considerations and Limitations

Category Safety Classification / Effect
Aspiration Hazard May be fatal if swallowed and enters the airways (aspiration toxicity).
Acute Toxicity Classified as Harmful if inhaled and Harmful in contact with skin (Acute Toxicity, Category 4).
Developmental Risk Suspected of damaging the unborn child (Reproductive Toxicity, Category 2), based on animal studies.
Flammability Classified as a Flammable liquid and vapor (Flammable Liquids, Category 3).
Monitoring Note Periodic liver and kidney function tests are recommended for those with frequent or high potential exposure.

Ксилен is generally Not Classifiable as to its Carcinogenicity to Humans (IARC Group 3), though specific regulatory warnings may vary. The overall safety structure emphasizes strict control of airborne concentrations to prevent acute CNS symptoms and long-term organ damage.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Using excessive amounts of Xylometazoline (Ксилен) or accidentally ingesting it can lead to serious systemic effects, particularly in children. As a topical nasal decongestant, Xylometazoline works locally, but a significant overdose can result in the medicine being absorbed into the body, affecting the central nervous system and cardiovascular system.

Signs and Symptoms of Overdose

Symptoms of a significant overdose can range from central nervous system depression to cardiovascular instability. Signs may include:

System Potential Symptoms
Cardiovascular Slow heart rate (bradycardia), fast heart rate (tachycardia), fluctuations in blood pressure (initial hypertension followed by hypotension).
Central Nervous System Drowsiness, lethargy, sedation, unresponsiveness, headache, dizziness, and, in severe cases, coma or convulsions.
Other Decreased body temperature (hypothermia), irregular or depressed breathing, paleness, or unusual sweating.

When to Seek Medical Help

Immediate emergency medical attention is mandatory if an overdose is suspected, especially if the product has been accidentally swallowed by a child or if any of the severe symptoms listed above occur in an adult or child. Due to the rapid onset of severe central nervous system effects, particularly in young children, contact a poison control center or seek emergency services right away. Do not wait for symptoms to worsen. Always keep this medication out of the sight and reach of children to prevent accidental ingestion.

Advertisements

Therapeutic Uses of Ксилен

Ксилен: Main Uses and Therapeutic Action

Ксилен (Xylometazoline) is a topical medication primarily used for the temporary relief of nasal congestion. This decongestant action is beneficial for individuals experiencing a blocked or stuffy nose due to several common conditions.

Therapeutic Applications

Ксилен is indicated for the symptomatic management of nasal congestion associated with:

  • The common cold
  • Hay fever and other respiratory allergies (allergic rhinitis)
  • Sinusitis

By helping to relieve the congestion, this medication facilitates easier breathing. The therapeutic benefit arises from its ability to constrict the blood vessels in the nasal lining, which helps decrease swelling of the nasal mucosa.

Quick Facts

Condition Treated Primary Therapeutic Benefit
Nasal Congestion (due to cold, allergies, sinusitis) Relief of stuffy nose, facilitates nasal airflow
Advertisements

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Ксилен — Official Regulatory Information

The eligibility for Ксилен (Xylometazoline) is strictly defined by regulatory documents based on the potential for systemic vasoconstriction. The official label outlines specific exclusions and conditions for use.

Eligibility Scope Status as per Regulatory Label
Populations Allowed Adults and adolescents aged 12 years and over (0.1% strength); Children 2 to 11 years (0.05% strength) [Source 1.6].
Populations Contraindicated Patients with narrow-angle glaucoma, atrophic rhinitis, rhinitis sicca, or who have undergone surgery exposing the dura mater [Source 1.6, 2.6].
Age-Related Exclusions Contraindicated for infants and children under 2 years of age, as safety and efficacy have not been established [Source 1.1, 1.6].

Condition-Based Restrictions (Use with Caution):

The medicine must be used with special caution, and often under medical supervision, in patients with pre-existing conditions that may be aggravated by sympathomimetic effects. These include hypertension, hyperthyroidism, diabetes mellitus, cardiovascular disorders (including Long QT syndrome), phaeochromocytoma, and prostatic hypertrophy [Source 1.6, 3.2].

Pregnancy and Lactation Eligibility Status:

Use is generally not recommended during pregnancy or lactation due to the drug's potential systemic vasoconstrictor effects [Source 1.6, 2.5]. If use is considered necessary, it is permissible only upon the specific advice of a healthcare provider [Source 2.5].

Regulatory Contraindication based on Concurrent Therapy:

The product is strictly prohibited for any patient currently receiving or who has received Monoamine Oxidase Inhibitors (MAOIs) within the last 14 days [Source 1.3].

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section describes the officially documented interaction patterns for Xylometazoline, focusing on regulatory-mandated restrictions and prohibitions found in government drug labels.


Documented Interaction Patterns

Interaction Type Interacting Substance/Class Official Regulatory Statement
Contraindicated Combination Monoamine Oxidase Inhibitors (MAOIs) Co-administration is prohibited due to the risk of causing a hypertensive crisis
Pharmacodynamic Risk Tricyclic and Tetra-cyclic Antidepressants Concurrent use may result in a rise in blood pressure due to potentiated sympathomimetic effects
Timing Restriction MAOIs (Discontinued Use) The product must not be used in patients who have received MAOIs within the preceding 14 days

Interaction-Related Restrictions and Cautions

The most significant interaction involves a contraindication with Monoamine Oxidase Inhibitors, a restriction necessary to prevent a severe systemic reaction resulting in acute hypertension. This prohibition is mandatory and includes a two-week separation rule following the discontinuation of the MAOI.

Furthermore, regulatory documents specify a caution for patients with Long QT syndrome, who have an officially documented increased risk of serious ventricular arrhythmias when using Xylometazoline. These requirements define the interaction profile by restricting use with other cardiovascularly active agents and noting risk in susceptible populations.

Advertisements

Mechanism of Action

The mechanism of action for Xylometazoline is centered on its direct interaction with the body's vascular control system, contributing to a reduction in the volume of interstitial fluid in the mucosal tissue.

Direct Activation of alpha-Adrenergic Receptors

This domain covers the primary molecular interaction of the drug, which involves Xylometazoline acting as a direct agonist on alpha-adrenergic receptors (alpha-adrenoceptors) located on blood vessel walls. This activation initiates the contraction of vascular smooth muscle, thereby mimicking an activation signal from the sympathetic nervous system and triggering the subsequent physiological cascade.

Modulation of Local Vascular Tone and Fluid Dynamics

The molecular activation directly translates into vasoconstriction (narrowing) of the nasal arterioles and venules, which governs this mechanistic domain. This action reduces the flow and pressure within the capillaries, which, in turn, limits the extravasation of fluid (plasma leakage) into the surrounding nasal tissue. The physiological effect is a reduction of mucosal edema, resulting in the decrease of mucosal tissue volume.

Functional Constraints: Receptor Desensitization

This domain addresses the drug's inherent mechanistic limitation, where prolonged or excessive exposure leads to tachyphylaxis via receptor desensitization. This constraint means that the alpha-adrenoceptors become progressively unresponsive to activation, which, upon drug cessation, can result in a paradoxical loss of vascular tone and a subsequent increase in mucosal edema, known as the rebound phenomenon.

Advertisements

Dosage and Administration Information

Ксилен (Xylometazoline) is a medication intended for intranasal local application only, delivered as a topical solution in the form of nasal drops or a metered-dose nasal spray. Usage patterns are characterized by patient age and the specific concentration used.


Dosage and Administration Protocol

The medication is supplied in two primary concentration strengths that determine the intended patient group. The 0.1% formulation is for use in adults and children 12 years of age and older, while the 0.05% concentration is for children between the ages of 6 and 12 years. Use of the 0.1% strength is contraindicated for children under 12 years of age.

The standard regimen involves the administration of 1 to 3 drops or sprays into each nostril. This application is typically limited to a maximum of three times per 24-hour period, with a minimum interval of 8 to 12 hours between doses.


Conditions of Use

A significant factor regarding the use of Xylometazoline is its duration. The medicine is intended for use over a short period of time. Continuous treatment generally does not exceed seven consecutive days, though some formulations specify a limit of three to five days. To facilitate administration, the nose is typically blown thoroughly before application. Additionally, for the nasal spray form, the pump is primed (actuated several times) prior to the first use to ensure a consistent dose is delivered. The administration follows the established dose and duration guidelines.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Ксилен

Evidence for Use in Nasal Congestion (Acute Rhinitis, Allergic Rhinitis)

This section summarizes the available clinical research regarding how Ксилен was studied for outcomes related to physical discomfort associated with nasal congestion in conditions like the common cold (acute rhinitis) and seasonal allergies (allergic rhinitis). Research explored outcomes reflecting daily functioning or activity level and patient-reported outcomes describing perceived discomfort associated with a blocked nose.

Studies typically monitored outcomes describing episodic or acute changes in nasal airflow and how symptoms evolved in the observed populations. Findings describe patterns observed in the studies where research participants reported changes in their nasal congestion over defined time intervals. However, research highlights changes measured during the study period and does not determine whether an individual will show similar patterns observed in the studies outside of a study setting. Comparative evidence against all other similar treatments is lacking in some studies.


Evidence for Use in Sinusitis and Otitis Media (As Adjunctive Therapy)

This part will outline studies that have evaluated the use of Ксилен as a supplementary treatment where research examined outcomes related to physical discomfort associated with breathing comfort in cases of sinusitis and otitis media. In these research scenarios, Ксилен was studied for temporary symptom changes related to blocked drainage. Studies explored whether the use of the medicine was associated with outcomes related to physiological strain or stress.

Evidence for this adjunctive use appears to be limited compared to evidence for simple nasal congestion. The role of the medication here is often evaluated in conjunction with other primary treatments, and data show patterns related to short-term symptom changes, but long-term effects on the overall course of these infections are not fully established.


Long-term Studies and Follow-up

This area summarizes what research has explored regarding the effects of using Ксилен over an extended period. Because this type of medication is typically used only for short durations, follow-up durations were limited in many of the studies that have been conducted. Research highlights changes measured during the study period but provides limited information for long-term outcomes.

Studies exploring how symptoms change over time usually focus on temporary symptom patterns, and the information available on the patterns of symptom evolution beyond short-term use is still emerging.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Ксилен (FAQ)


Q: What conditions is Ксилен most commonly prescribed or used for?

Regulatory documents indicate that Ксилен (Xylometazoline) is intended for the symptomatic relief of a blocked or stuffy nose. This includes congestion associated with various conditions such as the common cold (acute rhinitis), seasonal allergies (allergic rhinitis), and sinusitis.


Q: Is Ксилен primarily for viral infections or for allergy relief?

According to official product information, Ксилен acts as a decongestant and is indicated for use in both acute rhinitis (often caused by viral infections) and allergic rhinitis (caused by allergies). Its function is to reduce the swelling and ease the congestion, regardless of the underlying cause.


Q: Can Ксилен cause headaches or dizziness?

Yes, regulatory information lists both headache and dizziness as possible adverse reactions. Headache is sometimes reported as a common side effect, while dizziness may be listed among less common or rare effects. If these effects are experienced, individuals should consult with a healthcare professional.


Q: Is it common to feel a rapid or pounding heartbeat after using Ксилен?

Cardiac effects such as an increased heart rate (tachycardia) or a rapid, pounding heartbeat (palpitations) are listed in regulatory documents as very rare adverse reactions. These effects suggest that the medication may have some systemic influence on the body's circulation.


Q: Is there a risk of developing a tolerance to Ксилен over time?

Yes, official warnings advise that prolonged or frequent use of nasal decongestants like Ксилен may result in a diminished effect, which is a form of tolerance. This can lead to a paradoxical worsening of symptoms, known as rebound congestion or rhinitis medicamentosa, if the product is used beyond the recommended duration.


Q: Can I use Ксилен if I have cardiovascular disorders?

Official product information states that Ксилен should be used with caution in patients who have pre-existing cardiovascular disorders, including high blood pressure (hypertension) and a heart condition called Long QT syndrome. Patients with any heart conditions should seek guidance from a healthcare provider before use.


Q: Is a temporary burning or stinging sensation in the nose normal when using Ксилен?

According to official adverse reactions listings, it is common to experience temporary discomfort at the application site. This may include a burning sensation, stinging, or irritation in the nose when the product is first applied.


Q: Can Ксилен cause a dry nose or a runny nose as a side effect?

Yes, official documentation indicates that adverse effects can include symptoms related to the nasal lining. Common side effects can include a sensation of nasal dryness, and some users may experience an increase in nasal discharge (a runny nose).


Q: Can Ксилен affect sleep, causing trouble sleeping or insomnia?

As with other similar decongestants, the product should be used with caution in individuals who are sensitive to adrenergic substances. Official warnings note that a strong reaction to this class of medication can potentially manifest as insomnia (trouble sleeping).


Q: What are the signs of a possible allergic reaction to Ксилен?

Regulatory information lists hypersensitivity reactions as a very rare possibility. The signs of a severe allergic reaction can include swelling of the face or throat, a rash, or severe itching. If signs of a severe reaction occur, individuals should seek immediate medical attention.


Q: What should I do if I accidentally use Ксилен for longer than the recommended time?

If the product has been used frequently or for longer than the prescribed short period, the official warnings advise that nasal congestion may recur or worsen. If this occurs, regulatory advice suggests discontinuing use and seeking the guidance of a healthcare provider.


Q: What happens if Ксилен is accidentally swallowed?

Regulatory warnings state that if the product is swallowed, emergency medical assistance or contact with a Poison Control Center should be sought right away. Overdose symptoms can include effects on the central nervous system, changes in blood pressure, or alterations to the heart rate.


Q: Does the menthol/eucalyptus version of Ксилен have the same active ingredient?

Yes, the products labeled as containing Menthol or Eucalyptus typically use Xylometazoline hydrochloride as the core active decongestant ingredient. The added components are generally inactive substances included for sensory reasons.


Q: What should I do if my congestion seems worse after stopping Ксилен?

If congestion returns or becomes worse after stopping the medication, this may be a sign of rebound congestion. Regulatory documents advise that if this occurs, the medication should be discontinued and guidance from a healthcare provider should be sought.


Q: Does the use of Ксилен have any systemic effects on the body?

The amount of the drug that reaches the bloodstream after local nasal application is generally very low. However, systemic effects, particularly cardiovascular effects, are recognized as a possibility, especially in cases of overuse or in patients who are more sensitive to the medication.


Q: Is it safe to drive or operate machinery after using Ксилен?

Regulatory documents generally state that this medicine has very little or no effect on the ability to drive or use machines. However, individuals should avoid driving or operating machinery if they experience side effects such as dizziness or blurred vision.


Q: Can the effectiveness of Ксилен decrease if it's used frequently but within the recommended duration?

Yes, official warnings indicate that frequent use, even within the short recommended duration, can lead to a progressive decrease in effectiveness due to a process called receptor desensitization (a form of tolerance).


Q: If I miss an application of Ксилен, should I use extra next time?

Official dosing principles advise against exceeding the maximum number of doses within a 24-hour period. Therefore, users should adhere to the prescribed schedule and avoid compensating for a missed application with an extra dose.


Q: Is there any research on the long-term effects of using xylometazoline (the active ingredient in Ксилен)?

Studies and regulatory summaries confirm that this type of medication is intended for short-term use only. Because of this, the follow-up duration in most research is limited. Information on the effects and patterns of symptoms beyond the short-term use period is still emerging.

Advertisements

How should Ксилен be stored and disposed of?

The storage and disposal of Ксилен (Xylometazoline) must follow official instructions to maintain its quality and ensure safety.

Official Storage Conditions

The product must be stored below 30 C and protected from light and heat. The container should be kept tightly closed and the cap must be replaced immediately after use. It is mandatory to keep the medicine out of the sight and reach of children.

Stability and Disposal

Once the container is opened, the nasal drops must typically be discarded after 28 days (some labels specify up to 60 days), while sprays may have a longer stability period, such as 1 year. Unused or expired medicine must not be thrown away via wastewater or household waste; users are required to ask a pharmacist how to dispose of the medicine in accordance with local requirements.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ксилен found in:

A-Z Index: